RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy
August 18, 2025
August 18, 2025
BUFFALO, New York, Aug. 18 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy
*
BUFFALO, N.Y. -- About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn't respond to immunotherapy -- but results of a recent clinical trial show that an . . .
* * *
RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy
*
BUFFALO, N.Y. -- About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn't respond to immunotherapy -- but results of a recent clinical trial show that an . . .